Podcast appearances and mentions of max nisen

Bloomberg's June Grasso served as guest host. She was joined by Max Nisen, Bloomberg opinion columnist, Kermit Roosevelt, University of Pennsylvania Carey Law School Professor, Lester Munson, Principal at government relations firm, BGR Group, and Lincoln Mitchell, writer, political analyst and political science professor at Columbia University.

Bloomberg's June Grasso served as guest host. She was joined by Max Nisen, Bloomberg opinion columnist, Kermit Roosevelt, University of Pennsylvania Carey Law School Professor, Lester Munson, Principal at government relations firm, BGR Group, and Lincoln Mitchell, writer, political analyst and political science professor at Columbia University.

Guests: Greg Stohr, Bloomberg Supreme Court reporter, Katie Greifeld, Bloomberg Markets & ETFs Reporter, Emily Tisch Sussman, Host of "Your Presidential Playlist" Podcast and former VP of Campaigns for Center for American Progress, William McGinley, Principal at The Vogel Group, former White House Cabinet Secretary and former Deputy Counsel at the Republican National Committee, and Bloomberg Opinion columnist Max Nisen.

Guests: Greg Stohr, Bloomberg Supreme Court reporter, Katie Greifeld, Bloomberg Markets & ETFs Reporter, Emily Tisch Sussman, Host of "Your Presidential Playlist" Podcast and former VP of Campaigns for Center for American Progress, William McGinley, Principal at The Vogel Group, former White House Cabinet Secretary and former Deputy Counsel at the Republican National Committee, and Bloomberg Opinion columnist Max Nisen.

Max Nisen, Bloomberg Opinion biotech and health care columnist, on Pfizer's vaccine data showing it prevents 90% of covid infections. Mike Mayo, Senior Banking Analyst at Wells Fargo Securities, on the big day for the banks. Michael Zezas, Chief US Public Policy & Municipal Strategist for Morgan Stanley, on the importance of the Georgia runoff and his current strategy post-election. Thomas McLoughlin, Head of Americas Fixed Income at UBS Global Wealth Management, on bond markets after positive vaccine and election news. Hosted by Paul Sweeney and Vonnie Quinn. 

Guests: Wendy Benjaminson, Bloomberg politics editor, Mark Hamrick, Senior economic analyst at Bankrate.com, Nadeam Elshami, former Chief of Staff to House Democratic Leader Nancy Pelosi, Ted Harvey, Chairman of the Committee to Defend the President, and Bloomberg Opinion columnist Max Nisen.

Guests: Wendy Benjaminson, Bloomberg politics editor, Mark Hamrick, Senior economic analyst at Bankrate.com, Nadeam Elshami, former Chief of Staff to House Democratic Leader Nancy Pelosi, Ted Harvey, Chairman of the Committee to Defend the President, and Bloomberg Opinion columnist Max Nisen.

Phil Orlando, Chief Equity Market Strategist and Head of Client Portfolio Management at Federated Hermes, on how the election and White House covid crisis are clouding investment strategy. Bess Freedman, CEO of Brown Harris Stevens, discusses their 3Q Manhattan residential real estate report. Max Nisen, Biotech, Pharma and Health Care Columnist for Bloomberg Opinion, on how President Trump's serious covid meds contradict his stated condition. Jamie Metzl, Senior Fellow at The Atlantic Council and Founder and Chair of OneShared.World, discusses how Trump's covid diagnosis and White House chaos are threatening national security. Hosted by Paul Sweeney and Vonnie Quinn.

Phil Orlando, Chief Equity Market Strategist and Head of Client Portfolio Management at Federated Hermes, on equity markets and his current investment strategy. Ataman Ozyildirim, Senior Director, Economics & Global Research Chair at The Conference Board, on why the Leading Index points to the recovery losing steam. Natalie Wong, Bloomberg U.S. commercial real estate reporter, on desperate NYC landlords pressing the city's biggest employers to bring their employees back to the office. Max Nisen, Bloomberg Opinion Biotech, Pharma and Health Care Columnist, discusses his new column: "SalivaDirect Could Kick Off a U.S. Testing Turnaround." Hosted by Paul Sweeney and Vonnie Quinn.

Max Nisen, Biotech, Pharma and Health Care Columnist for Bloomberg Opinion, discusses his column: "Kodak Craziness Is Captured in One Word. Really?" David Kotok, Chairman & Chief Investment Officer at Cumberland Advisors, on fiscal stimulus, the pandemic, and investment outlook. Dr. David Skorton, president and chief executive of the Association of American Medical Colleges, discusses his Washington Post column: "We Need a Covid-19 Reset. So We Developed a Comprehensive Plan to Do Just That." Barry Ritholtz, Founder of Ritholtz Wealth Management, Bloomberg Opinion columnist, and Host of Masters of Business, on whether tech companies will face the music on regulation. Hosted by Paul Sweeney and Vonnie Quinn. 

KodakFor a company that became famous for making camera film, and then became infamous, and bankrupt, for missing the shift to digital photography, Ea... talked about Kodaktalkedtwiceweird licensing dealannual reportchanged its name to Long Blockchain Corp.announcementand and andMax NisenIt had the expected effectnotcall this stuffbankrupt stockssoaringinstrumentsalso there is thissecurities regulationannouncing itconsistentthemetestified before CongressBezosstockconvertible bondspaid large feesthat is not truebanks love SPACsI wrote a little bitthere are more hereTrading Rallylaunches restructuringHefty ChargesPoint72Run by a RobotprofileCLO BetGot a Head Startcity slickersFoxsubscribe at this linkheregave up on the blockchain in 2019filed annual or quarterly reportsRegulation FDthe hearing videoFarhad Manjooit did until recently

Sports veteran Neal Pilson, founder and president of Pilson Communications, and former President of CBS Sports, on the outlook for sports programming and advertising, as the sports shutdown takes a toll. Ken Leon, Global Director of Industry and Equity Research at CFRA Research, on bank earnings. Max Nisen, Bloomberg Opinion biotech and health care columnist, on coronavirus antibodies and the rising covid death rate in the U.S. George Ferguson, Senior Aerospace, Defense & Airlines Analyst for Bloomberg Intelligence, on the faltering demand for air travel. Hosted by Paul Sweeney and Vonnie Quinn.

Guests: Republican Iowa Senator Joni Ernst, Max Nisen, Bloomberg Opinion columnist, Thomas Tighe, CEO and President of Direct Relief, Republican Texas Congressman Michael McCaul, Roger Fisk, Democratic Strategist and Principal of New Day Strategy. 

Guests: Republican Iowa Senator Joni Ernst, Max Nisen, Bloomberg Opinion columnist, Thomas Tighe, CEO and President of Direct Relief, Republican Texas Congressman Michael McCaul, Roger Fisk, Democratic Strategist and Principal of New Day Strategy. 

Bloomberg's Jef Feeley, legal reporter, and Katherine Chiglinsky, insurance reporter, to discuss Tesla's new lawsuit shield against coronavirus claims. Chris Ailman, Chief Investment Officer at CalSTERS, on market volatility and the return to risk assets. Greg Stohr, Bloomberg legal reporter, on the Supreme Court decision to protect LGBT workers. Max Nisen, Bloomberg Opinion biotech and health care columnist, on why getting a flu shot this year will help in the battle against covid-19. Hosted by Paul Sweeney and Vonnie Quinn. 

Vincent is joined by Max Nisen from Bloomberg to discuss AstraZeneca, Pascal Soriot and the race of Big Pharma to develop a vaccine for Covid-19. He's also joined by Jon Ihle a former financial journalist and now Head of Communications with Goodbody to talk about rise of trading app Robinhood and its impact on the markets. German MEP David McAllister, who leads the European Parliament's UK Coordination Group is also on to discuss the positon of Brexit negotiations and prospects for a deal. Listen and subscribe to Taking Stock with Vincent Wall on Apple Podcasts, Google Podcasts and Spotify.      Download, listen and subscribe on the Newstalk App.     You can also listen to Newstalk live on newstalk.com or on Alexa, by adding the Newstalk skill and asking: 'Alexa, play Newstalk'.

Max Nisen, Bloomberg Opinion biotech, pharma and health care columnist, discusses why it's still early days for Moderna's virus vaccine. Lisa Knee, co-leader for the national real estate practice at Eisner Amper, on the commercial real estate landscape. Burt Flickinger, Managing Director at Strategic Resource Group, on why J.C. Penney will still be viable after filing for bankruptcy. Don McCree, Vice Chairman and Head of Commercial Banking at Citizens Bank, on banking and small business lending. Hosted by Lisa Abramowicz and Paul Sweeney.

Karen Ubelhart, Senior Industrials analyst for Bloomberg Intelligence, on 3M and Caterpillar earnings. Ellen Wald, President of Transversal Consulting and a Bloomberg Opinion contributor, on why the oil crisis will spill over into midstream companies. Jim Paulsen, Chief Investment Strategist at Leuthold Group, on why he's adding out-of-favor sectors on weakness. Max Nisen, Bloomberg Opinion Health Care columnist, with a coronavirus update, and a look at Big Pharma earnings. Hosted by Lisa Abramowicz and Paul Sweeney.

Andy Slavitt, Former Acting Administrator for Medicare and Medicaid Services, on asking Americans to stay home, and upcoming strain on the U.S. health care system. Peter Tchir, Head of Macro Strategies at Academy Securities, on why he would put a little risk on. Gaurang Shastri, Managing Director and Head of Lincoln Internationals’ North American Logistics & Transportation, on impact of coronavirus on ports and supply chains. Max Nisen, Bloomberg Opinion health care columnist, on the coronavirus hospitalization rate.

Carl Weinberg, Founder and Chief International Economist of High Frequency Economics, on the monetary and fiscal response to the coronavirus. David Garrity, Chief Market Strategist for Laidlaw & Co, and Partner at BTblock, discusses markets, bottom for tech, and changes to consumer behavior. Max Nisen, Bloomberg Opinion health care columnist, with a coronavirus testing update.

Steve Blitz, Chief U.S Economist at TS Lombard, on central banks and the Fed QE plan. Marian Harkin, Irish Parliament member and former member of the European Parliament, on how Ireland is managing the coronavirus crisis, and European stimulus. Max Nisen, Bloomberg Opinion health care columnist, on the U.S. coronavirus failure. Scott Soshnick, Bloomberg sports columnist, discusses the near-shutdown of U.S. sports.

Paranoia about the coronavirus is spreading rapidly around the world, and the reaction in financial markets has been swift. Principal Global Investors strategist Seema Shah discusses how the “velocity of risk” is much faster now than it was during the outbreak of a similar virus, severe acute respiratory syndrome or SARS, in 2003. Also joining the podcast is Bloomberg Opinion’s health-care columnist Max Nisen, who explains how the clinical trial process and the profit incentives for drugmakers mean the quick development of a coronavirus vaccine is unlikely. Mentioned in this podcast: The Market Is Trying to Put a Price on the Coronavirus Outbreak

 Dan Daviau, CEO of Canaccord Genuity, talks about his outlook for 2020 for markets and beaten down cannabis sector. Vincent Deluard, Global Macro Strategist for INTL FCStone (NASDAQ: INTL), discusses his latest report, "Six Reasons for EM Outperformance in 2020. Max Nisen, Bloomberg Opinion health care columnist, on Obamacare in jeopardy after a federal court struck down the Obamacare individual mandate. Seema Shah, Director Consumer and Retail Trends at Creditntell, with a holiday retail preview. Hosted by Lisa Abramowicz and Paul Sweeney.

Mario Tadeo, Bloomberg News EMEA Reporter, will discuss the latest on Brexit. Troy Gayeski, Co-Chief Investment Officer at Skybridge, will discuss the current developments in the China trade war and its impact on markets. Max Nisen, Bloomberg Healthcare Columnist, will discuss news that the three largest U.S. drug distributors and a major generic-drug manufacturer, have agreed to pay more than $250 million to settle the first federal trial over the companies’ role in fueling the U.S. opioid epidemic. Derek Forbes, CEO of Stardust, on how interactive consumer tech allows businesses to develop a deeper understanding of their customers.

Tom Gimbel, Founder and CEO of LaSalle Network, discusses the September payroll report and the relationship between low unemployment and wage figures. Doug Cohen, Managing Director at Athena Capital Advisors, discusses the September labor report, the outlook for Fed rate cuts, and US-China trade. Max Nisen, Bloomberg Opinion Biotech, Pharma and Health Care Columnist, discusses the Trump Administration’s executive order aimed at steering more seniors into privately managed Medicare Advantage plans instead of traditional Medicare. Becky Frankiewicz, President of Manpower Group Inc, discusses the jobs report and the retail sector, where it’s become increasingly challenging to find holiday workers.

Max Nisen, Bloomberg Opinion health care columnist, on the need for aggressive FDA regulation and oversight of e-cigarettes. Kit Juckes, Global Fixed Income Strategist for Societe Generale, on the ECB rate decision and why QE isn't the answer for growth. Mike Massaro, CEO of Flywire, on the massive shift undergoing the payments industry. Harvard Business School Professor and former investment banker Vikram Gandhi on impact and sustainable investing. Hosted by Lisa Abramowicz and Paul Sweeney.

Paul Greer, Portfolio Manager, Emerging Markets & FX at Fidelity International, on the short-term risk of emerging market contagion. Grady Burkett, portfolio manager at Diamond Hill Capital Management, on finding value in global markets, and why he’s overweight the U.K. Max Nisen, Bloomberg Opinion health care columnist, on why Trump's plan to import cheap Canadian drugs can't happen without Big Pharma. Michelle Seitz, Chairman and Chief Executive Officer of Russell Investments, on industry trends in asset management and the survival of the fittest. Hosted by Lisa Abramowicz and Paul Sweeney.

Dr. Win Thin, Global Head: Currency Strategy for Brown Brothers Harriman, discusses the pound sinking on hard Brexit fears, and the dollar ahead of the Fed decision. Dan Ives, Managing Director and Equity Analyst covering the Technology sector at Wedbush Securities, on tech earnings and what to expect from Apple. Max Nisen, Bloomberg Opinion health care columnist, on why the Pfizer-Mylan combo solves two problems with one deal. Terrell Gates, CEO of Virtus Real Estate Capital, an Austin-based private equity firm, on which commercial real estate investments are more immune to downturns. Hosted by Lisa Abramowicz and Paul Sweeney (Alix Steel filling in for Lisa Abramowicz.) 

Rebecca Spalding, Bloomberg News Biotech Reporter, and Max Nisen, Bloomberg Opinion Health Care Columnist, break down AbbVie agreeing to pay $63 billion for rival drugmaker Allergan, the latest huge merger in a pharmaceutical sector rapidly being reshaped by deals. Sarah McGregor, Bloomberg News U.S. Economic Policy Team Leader, explains that U.S. is willing to suspend the next round of tariffs on an additional $300 billion of Chinese imports while Beijing and Washington prepare to resume trade negotiations. Connor Browne, Portfolio Manager at Thornburg Investments, talks about stocks in his long/short strategy. Businessweek Editor Joel Weber and Bloomberg News Venture Capital ReporterSarah McBride discuss how using technology can be used to protect parts of Redwood trees. And we Drive to the Close with Joe Barrato, CEO at Arrow Investment Advisors. Hosts: Carol Massar and Jason Kelly.  Producer: Paul Brennan  Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Rebecca Spalding, Bloomberg News Biotech Reporter, and Max Nisen, Bloomberg Opinion Health Care Columnist, break down AbbVie agreeing to pay $63 billion for rival drugmaker Allergan, the latest huge merger in a pharmaceutical sector rapidly being reshaped by deals. Sarah McGregor, Bloomberg News U.S. Economic Policy Team Leader, explains that U.S. is willing to suspend the next round of tariffs on an additional $300 billion of Chinese imports while Beijing and Washington prepare to resume trade negotiations. Connor Browne, Portfolio Manager at Thornburg Investments, talks about stocks in his long/short strategy. Businessweek Editor Joel Weber and Bloomberg News Venture Capital ReporterSarah McBride discuss how using technology can be used to protect parts of Redwood trees. And we Drive to the Close with Joe Barrato, CEO at Arrow Investment Advisors. Hosts: Carol Massar and Jason Kelly.  Producer: Paul Brennan 

Max Nisen, Bloomberg Opinion health care columnist, on AbbVie buying Botox maker Allergan for $63 billion. CoinShares Chairman Danny Masters discusses the bitcoin rally and Facebook's new Libra cryptocurrency. Lynn Franco, Senior Director of Economic Indicators and Surveys at The Conference Board, discusses how trade and tariffs worries are draining consumer confidence.  Hal Brands, the Henry A. Kissinger Distinguished Professor at Johns Hopkins University and a Bloomberg Opinion columnist, discusses Trump mulling ending the postwar defense pact with Japan. Hosted by Lisa Abramowicz and Paul Sweeney.

Michael Sonnenfeldt, Chairman of TIGER 21, on how the ultra-wealthy are investing after Q1. Michael Terwilliger, Portfolio Manager for the Resource Credit Income Fund, on how a new 48-hour trade reporting delay for corporate bonds could impact the market. Max Nisen, Biotech, Pharma and Health Care Columnist for Bloomberg Opinion, on Johnson & Johnson’s better than expected drug sales, and UnitedHealth raising their outlook. Damian Sassower, Chief Emerging Markets Credit Strategist for Bloomberg Intelligence, on how Venezuela sanctions are keeping investors away.  Hosted by Lisa Abramowicz and Paul Sweeney. 

David Kelly, JPMorgan Asset Management Chief Global Strategist, says monetary policy tools are ineffective. Frances Donald, Manulife Asset Management Head of Macroeconomic Strategy, expects a recession in 2020. Jane Foley, Rabobank Head of FX Strategy, is cautious about EM. Max Nisen, Bloomberg Opinion Healthcare Columnist, says 20 million people would lose coverage if Obamacare is struck down.   Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

David Kelly, JPMorgan Asset Management Chief Global Strategist, says monetary policy tools are ineffective. Frances Donald, Manulife Asset Management Head of Macroeconomic Strategy, expects a recession in 2020. Jane Foley, Rabobank Head of FX Strategy, is cautious about EM. Max Nisen, Bloomberg Opinion Healthcare Columnist, says 20 million people would lose coverage if Obamacare is struck down.  

Greg Vesey, CEO & Managing Director of LNG Ltd., on the future of LNG and growing demand in Asia and Europe.  John Lavelle, President & CEO, Offshore Wind, GE Renewable Energy, on the offshore wind boom. Paul Browning, President and CEO of Mitsubishi Hitachi Power Systems Americas (MHPSA), on “power to gas” solutions for energy storage, the growing role of hydrogen, and the impact of AI and automation on the industry. Max Nisen, Bloomberg biotech, pharma and health care columnist, on Trump's shift to completely erase Obamacare, including its popular rules protecting pre-existing conditions.

Max Nisen, Bloomberg Opinion health care columnist, on Biogen plunging after the company and its partner Eisai announced it was halting their Alzheimer drug trial. Gad Levanon, Chief Economist: North America at the Conference Board, on the February Leading Index and the Fed decision. Bill Zox, CIO of Fixed income at Diamond Hill Capital Management, to discuss the Fed, the fixed income markets and where he sees opportunities.  Chen Grazutis, Apparel and Footwear Analyst from Bloomberg Intelligence, on the valuation for Levi Strauss IPO. Hosted by Lisa Abramowicz and Paul Sweeney. 

Joining in studio is Max Nisen, Bloomberg Opinion Pharm and Health Care Columnist on Health care costs on big companies like Ford. Also joining in studio is Joel Stern, Chairman and CEO of Stern Value Management, on why Trump's policies will help avert a recession for several more years. Another guest in studio is Bradley Tusk, founder and CEO of Tusk Philanthropies, on their national effort to expand mobile voting: Denver will implement Tusk's blockchain-based mobile voting pilot in its May municipal election. And lastly we will have Chad Oviatt, Director of Investments for Huntington Private Banking on markets, sectors and companies.Hosted by Abramowicz and Paul Sweeney. 

Charlie Bobrinskoy, Vice Chairman, Head of the Investment Group and Portfolio Manager at Ariel Investments, discusses markets, and weathering a downturn. Karen Ubelhart, Senior Industrials Analyst for Bloomberg Intelligence, on GE's power unit facing a multi-year slump. Max Nisen, Bloomberg Opinion health care columnist, on JNJ's new nasal spray for depression. Carl Riccadonna, Chief US Economist for Bloomberg Economics, on former NY Fed President Bill Dudley's column, "Don’t Assume The Fed Is Done Raising Rates." Hosted by Abramowicz and Paul Sweeney. 

Max Nisen, Bloomberg Opinion health care columnist, discusses his column, "Celebration of Obamacare’s Death Is Again Premature."  Alex Spinelli, former head of Amazon’s Alexa, discusses his new AI creation – “Maven," his big initiative as Global CTO of AI bot maker LivePerson. Brendan Ahern, CIO of KraneShares, on China’s weak economic data, and current investment strategies. Matt Toms, CIO of Fixed Income at Voya Investment Management, to discuss his 2019 outlook for fixed income.  Hosted by Pimm Foxx and Lisa Ambramowicz.

Constance Hunter, Chief Economist at KPMG, on GDP numbers, the Fed and economic outlook. David Garrity, Chief Market Strategist for Laidlaw & Co. LTD, on Google and Amazon earnings, and the tech sector fallout. Anand Srinivasan, Senior Semiconductor and Hardware Analyst for Bloomberg Intelligence, on the chip sector, and how the big names compare: Intel, AMD, Western Digital. Max Nisen, Bloomberg Opinion columnist covering health care, on why Trump's new drug pricing plan has real teeth.

Max Nisen, Bloomberg Opinion health care columnist, on Pfizer agreeing to delay price increases after Trump called the company out. Vacit Arat, co-founder and President of HIA Technologies Inc., on creating Digital Avatars, which can carry on a sophisticated conversation with humans on almost any subject in any language.Carl Weinberg, Chief Economist at High Frequency Economics, on how China could hurt the US once it runs out of imports to tax.David Garrity, CEO of GVA Research, on how blockchain is being implemented in the real economy and outlook for Twitter.

Bloomberg Opinion’s Max Nisen, health care columnist, and Shira Ovide, technology columnist, on Amazon buying Pillback.Chris Whalen, Chairman of Whalen Global Advisors, on bank stocks continued losing streak, and the privatization of Fannie and Freddie. Leland Miler, CEO of China Beige Book, on trade with China, and China Q2 economic data. Brian Egger, Senior Gaming & Lodging Analyst for Bloomberg Intelligence, on two new casinos-- Hard Rock and Ocean Resort- opening in Atlantic City.

Damian Sassower, Fixed Income Strategist for Bloomberg Intelligence, on whether we are reaching the bottom for EM. Elizabeth Nyamayaro, Senior Advisor to the Under Secretary-General and Executive Director of UN Women, and Head of the HeForShe Initiative, on the critical issues facing women around the globe.Anil Dash, CEO of Fog Creek Software, on how to make big tech more ethical and closing the gender pay gap.Max Nisen, Bloomberg Opinion columnist covering health care, on the Takeda-Shire deal. Broadcasting live from BLOOMBERG’s BUSINESS OF EQUALITY SUMMIT in the New York City corporate headquarters.

FOCUS ON FIXED INCOME: Damian Sassower, fixed income strategist for Bloomberg Intelligence, on emerging market debt and what higher US yields mean for EM.Jason Trennert, Chairman and Chief Investment Officer of Strategas Research Partners, on why the real economy will outperform the market in 2018.Alex Webb, Bloomberg Gadfly columnist covering technology, on Google's spending surge and Apple manufacturers signaling slowdown in iPhone demand.Max Nisen, Bloomberg Gadfly health care columnist, on Takeda close to buying Shire, and today's big health care earnings.

Masters in Business Host Barry Ritholtz joins Carol and they speak to Spencer Soper, Bloomberg News Tech Reporter, and Jitendra Waral, Bloomberg Intelligence Global Internet Analyst, on Amazon exceeding 100 million Prime subscribers. Max Nisen, Bloomberg Gadfly Health Care Columnist, discusses Allergan announcing that it does not intend to make an offer for Shire.Michael Ludden, Director of Product at IBM Watson Developer Labs, talks about Artificial Intelligence, Augmented & Virtual Reality in “The Future of Immersive Storytelling.” Ramon Llamas, Research Director at IDC, and Abhey Lamba, Analyst at Mizuho Securities, explain how a possible slowing of demand for smartphones may impact on Apple. 

Masters in Business Host Barry Ritholtz joins Carol and they speak to Spencer Soper, Bloomberg News Tech Reporter, and Jitendra Waral, Bloomberg Intelligence Global Internet Analyst, on Amazon exceeding 100 million Prime subscribers. Max Nisen, Bloomberg Gadfly Health Care Columnist, discusses Allergan announcing that it does not intend to make an offer for Shire.Michael Ludden, Director of Product at IBM Watson Developer Labs, talks about Artificial Intelligence, Augmented & Virtual Reality in “The Future of Immersive Storytelling.” Ramon Llamas, Research Director at IDC, and Abhey Lamba, Analyst at Mizuho Securities, explain how a possible slowing of demand for smartphones may impact on Apple.  Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Guests:Philippe Houchois, equity analyst at Jefferies, on why he thinks investors should hold onto Tesla, as the stock comes under pressure amidst production concerns.Banker to the world Bill Rhodes, President and CEO of William Rhodes Global Advisors, on China tariffs and outlook for trade war.Bloomberg Gadfly’s Max Nisen, health care columnist, and Tara Lachapelle, deals columnist, on why a Walmart-Humana makes sense.Jennifer Bartashus, consumer analyst for Bloomberg Intelligence, on a California ruling that will require coffee sellers and retailers like Starbucks to issue cancer warnings.

Jack Devine, former Acting Director of the CIA and President of security firm The Arkin Group, and Toby Harshaw, Bloomberg View editor, discuss President Trump upcoming meeting with North Korea's Kim Jong Un.Noel Hebert, Director of Credit Research for Bloomberg Intelligence, on Toys R Us said to prepare for a shutdown of its US operations, and Claire's preparing to file bankruptcy. Tad Rivelle, Chief Investment Officer for Fixed Income at TCW Group, on the bond markets and current investment strategy. Max Nisen, Bloomberg Gadfly columnist covering health care, discuss the health care industry landscape following the Express Scripts-Cigna, and potential anti-trust issues.

Eric Stein, Co-Director of Global Income at Eaton Vance, on the bond market, the yield curve and EM debt.Max Nisen, Bloomberg Gadfly health care columnist, on Blue Cross of Idaho offering insurance plans that do not comply with Obamacare law, and don’t cover pre-existing conditions.Axel Merk, President and CIO of Merk Investments, with market insights on the dollar, gold, and how institutional investors should be handling volatility and risk.Karen Ubelhart, Industrials analyst for Bloomberg Intelligence, on Deere raising its sales forecast amid signs of a farm economy recovery.

Chris Rupkey, MUFG Union Bank Chief Financial Economist, asks how Washington will pay for new infrastructure and healthcare programs following the tax cuts. Max Nisen, Bloomberg Gadfly Columnist, joins to breakdown the news that JPMorgan, Amazon, and Berkshire Hathaway are partnering to create a healthcare company for their U.S. Employees. Terry Haines, Evercore ISI Head of U.S. Policy & Political Analysis, says he'll be listening for signals on housing finance and trade in President Trump's State of the Union Address tonight. Emily Roland, John Hancock Investments Head of Capital Markets Research, says it's likely we'll see an increase in volatility in 2018.  Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Chris Rupkey, MUFG Union Bank Chief Financial Economist, asks how Washington will pay for new infrastructure and healthcare programs following the tax cuts. Max Nisen, Bloomberg Gadfly Columnist, joins to breakdown the news that JPMorgan, Amazon, and Berkshire Hathaway are partnering to create a healthcare company for their U.S. Employees. Terry Haines, Evercore ISI Head of U.S. Policy & Political Analysis, says he'll be listening for signals on housing finance and trade in President Trump's State of the Union Address tonight. Emily Roland, John Hancock Investments Head of Capital Markets Research, says it's likely we'll see an increase in volatility in 2018. 

Max Nisen, Bloomberg Gadfly columnist covering health care, on Amazon, Berkshire and JP Morgan setting up a health company for their staff, and as a look at Pfizer and Aetna earnings.Robert Lawrence, the Albert L Williams Professor of International Trade and Investment at Harvard Kennedy School, on trade outlook for the US and NAFTA, and how it could impact the economy. Scott Shapiro, CEO of STATE Optical, on starting a luxury eyewear manufacturing business in the US and the company outlook.  Ira Jersey, Chief US interest rate strategist for Bloomberg Intelligence, on the FOMC meeting this week, and why there won't necessarily be a big pension fund reallocation into fixed income.

Keith Noreika, Former Acting Comptroller of the Currency, discusses banking charters for tech firms, outlook for changes to the banking industry, and bitcoin as a currency.Max Nisen, Bloomberg Gadfly columnist covering health care, on biotech M&A, and what to expect from the big pharma earnings this week.Jonathan Adams, Senior Insurance Industry Analyst, on AIG acquiring Validus after years of retrenchment. Karen Ubelhart, industrials analyst for Bloomberg Intelligence, on GE and how great franchises within the company are being overlooked.

Max Nisen, Biotech, Pharma and Healthcare Columnist for Bloomberg Gadfly, on his article “A Humana Deal Would Escalate the Insurance Arms Race: Gadfly”. We also have Alberto Gallo, Portfolio Manager and Head of Macro Strategies at Algebris Investments, on his investment outlook for 2018. Joseph Lubin, Ethereum Co-Founder & founder of Global Blockchain Specialist Consensys, on why Ether's growth will continue. Also joining is David Lee, COO and CFO of Impossible Foods, on their plant-based "meat" burgers, why Bill Gates is an investor, and growth outlook. 

Christine Kawano Usyak is an education professional with experience teaching, leading, and mentoring at organizations as diverse as Apple, Amazon, and a first-grade classroom. In this episode she and Morris talk about leading adults vs. kids, mentoring and being mentored, finding focus, and work/life balance. First, though, we talk about a question that mixed-race people can find themselves getting asked dozens of times a day: “Where are you from?” Show Notes“A mission to capture the full range of half-Japanese experience — in 192 photos,” an excellent article by Louise George Kittaka in the Japan Times about the Hāfu2Hāfu project.International School (Wikipedia)iPhone X (Wikipedia)2011 Tohoku earthquake and tsunami (Wikipedia)What’s the origin of the phrase “raise the bar”? (Quora)“Why Stack Ranking Is A Terrible Way To Motivate Employees”, a 2013 article by Max Nisen in Business Insider.“Inside Amazon: Wrestling Big Ideas in a Bruising Workplace”, a 2015 article by Jodi Kantor and David Streitfeld in the New York TimesAesop (Wikipedia)

Kathleen Gaffney, co-director of diversified fixed income at Eaton Vance, talks about bond markets, investment strategy and high-yield. Shira Ovide, a Bloomberg Gadfly columnist covering technology, and David Garrity, CEO of GVA Research, discuss the domination of Amazon. Jim Harrison, CEO of Party City, talks about new channels of revenue growth and his company's vertical business model. Finally, Max Nisen, a Bloomberg Gadfly columnist covering health care, talks about vertical consolidation deals popping up in health care, like CVS-Aetna, and Amazon entering into the prescription drug segment. 

Max Nisen, a Bloomberg Gadfly columnist, tells Pimm Fox and Lisa Abramowicz how Donald Trump's executive order allowing the sale of less-comprehensive health care plans will impact Obamacare. Frank Sorrentino, CEO of ConnectOne Bank, talks about the growth of fintech in community banking. Cognizant's Ben Pring, co-leader of the Future of Work Center, discusses his new book, "What To Do When Machines Do Everything: How to Get Ahead in a World of AI, Algorithms, Bots and Big Data." Finally, Kevin Cirilli, a White House correspondent at Bloomberg, talks about reports that Trump is said to be seeking a change to ending a tax break for people in high-tax states.

Max Nisen, a Bloomberg Gadfly columnist covering health care, talks about the GOP's newly revised Trumpcare bill. Carl Riccadonna, the chief U.S. economist for Bloomberg Intelligence, weighs in on Fed Chair Yellen's testimony to the Senate Banking Committee.

Matt Maley, an equity strategist at Miller Tabak & Co., talks about bank earnings and why Congress needs to shoulder responsibility for the lack of fiscal policy. Max Nisen, a Bloomberg Gadfly columnist covering health care, talks about news that Senator McConnell is floating a potential bipartisan fix of Obamacare. Sal Gilbertie, the president and founder of Teucrium Trading LLC, and Mike McGlone, a commodity strategist at Bloomberg Intelligence, discuss agricultural commodities and how the drought and demand could impact wheat and corn prices. Finally, Bloomberg's Laura Keller says Wall Street is dulled by a renewed trading slump.

Bloomberg Markets with Carol Massar and Cory Johnson. GUESTS: Max Baucus Former U.S. Senator and Ambassador to China Discussing the Republican draft bill to repeal and replace Obamacare with Bloomberg Gadly columnist Max Nisen.

Bloomberg Markets with Carol Massar and Cory Johnson. GUESTS: Max Baucus Former U.S. Senator and Ambassador to China Discussing the Republican draft bill to repeal and replace Obamacare with Bloomberg Gadly columnist Max Nisen. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Max Nisen, a Bloomberg Gadfly columnist covering health care, says the Senate Trumpcare bill doesn't age well. John Kilduff, a founding partner of Again Capital, tells Pimm Fox and Lisa Abramowicz why oil will likely dip into the $30 range. Bloomberg's Michael Sasso and Deena Kamel discuss news that Qatar Airways is taking a state in American Airlines. Finally, Brendan Brown, chief economist and head of economic research at Mitsubishi UFJ Securities, talks about asset price inflation and how Trump and the GOP have squandered the opportunity to tackle monetary disorder.

Former Treasury Secretary Larry Summers, president emeritus and Charles W. Eliot University professor at Harvard University, discusses bank regulation, U.S. Treasury policies and an outlook for recession. Matt Freund, co-chief investment officer and head of fixed income strategies at Calamos Investments, tells Lisa Abramowicz why he expects rates to re-test lows in the next recession. Alicia Garcia Herrero, chief economist for the Asia Pacific region at Natixis, discusses the outlook for China and Asia markets. Finally, Max Nisen, a Bloomberg Gadfly columnist, talks about insurers raising Obamacare premiums as they fret over the bill's shaky future.

Bloomberg Gadfly columnist Max Nisen talks about what can be expected in the Senate after the House passed the American Health Care Act. John Cochrane, a senior fellow at the Hoover Institution, discusses wage growth and monetary policy. Bloomberg's Ira Jersey says yields won't necessarily move higher when the Fed shrinks its balance sheet. Finally, Joe Mysak, a municipal bond editor at Bloomberg Briefs, discusses Puerto Rico.

Conor Sen, a Bloomberg View columnist and money manager at New River Investments, says Donald Trump's infrastructure plan would require an additional 570,000 construction workers. David Kudla, CEO and chief investment strategist of Mainstay Capital, discusses markets and investments, the Fed and his current stock picks. Max Nisen, a Bloomberg Gadfly columnist, discusses Roche's successful patient study on its breast cancer drug and the outlook for Valeant. Finally, Rob Barnett, a senior energy policy analyst at Bloomberg Intelligence, discusses the Trump administration's proposal to slash the EPA's budget by 25 percent.

Libby Toudouze, a partner and money manager at Cushing Asset Management, says Williams Partners is in the sweet spot of the energy "renaissance." Michael Scanlon, a money manager at Manulife Asset Management, previews Apple earnings. Max Nisen, a Bloomberg Gadfly columnist covering health care, discusses Eli Lilly and Pfizer earnings, Teva's plunge after patents were invalidated and Donald Trump's meeting with the pharmaceutical industry representatives today. Finally, Patrick Donahue, a German government reporter for Bloomberg in Berlin, discusses Trump adviser Peter Navarro criticizing Germany for exploiting an "undervalued" euro.

Scott Rothbort, president of LakeView Asset Management, talks about the changing nature of the retail industry, Wal-Mart's outlook and why Chipotle has lost its way. Then, Pimm Fox and Lisa Abramowicz talk to Max Nisen, a Bloomberg Gadfly columnist, about pharma and biotech stocks sinking after Donald Trump's tweet to "bring down drug prices." Also, Brandon Barnes, senior litigation analyst for Bloomberg Intelligence, discusses why the Dakota Access pipeline owners have a strong chance to reverse the Army Corps of Engineer's refusal to grant the final permit needed. Finally, Shira Ovide, a Bloomberg Gadfly columnist, goes over tech news, including Trump saying SoftBank will create 50,000 jobs in the U.S.

It's the big question everyone's asking in the M&A world: Will Donald Trump stay true to his business roots and champion mega-mergers, or will his protectionist, anti-media, anti-lobbyist tendencies lead to an administration that's tough on big corporations? Bloomberg Gadfly columnists Tara Lachapelle and Max Nisen give their opinions to host Alex Sherman.

While they aren't household names, but utility deals are likely to drive 2016 M&A, reporter Matt Monks tells Deal of the Week host Alex Sherman. They discuss why an $8.6 billion takeover of Midwestern energy producer Westar by Great Plains Energy proves industry consolidation isn't slowing down, and Monks offers a few suggestions for future deal targets. Plus, Gadfly columnist Max Nisen says he can't see a situation where anyone buys Valeant, even though the stock spiked on last week's Wall Street Journal report that Japanese pharma firm Takeda and private equity giant TPG approached the floundering company about a possible takeover.

You don't need to go to college to become successful. What Americans call education is usually just the passing along of traditional wisdom, which, when you think about it, is essentially a deepening of the status quo: conformity, indoctrination, groupthink. When students can imitate their teachers perfectly, we claim they have achieved excellence. But aren't they just imitating the norm, the average, the standard? If this is excellence, where will we find progress? I'm not the only one who feels this way. Laszlo Bock is the head of people operations at Google.In a conversation with Tom Friedman of The New York Times reported by Max Nisen at Quartz, Bock made a startling series of statements about what Google has learned from studying its own employees: Graduates of top schools often lack “intellectual humility”“They commit the fundamental attribution error, which is if something good happens, it's because I'm a genius. If something bad happens, it's because someone's an idiot or I didn't get the resources or the market moved.” People that make it without college are often the most exceptional.“When you look at people who don't go to school and yet make their way in the world, those are exceptional human beings. And we should do everything we can to find those people…. What we've seen [at Google] is that the people who are the most successful here, who we want to hire, will have a fierce position. They'll argue like hell. They'll be zealots about their point of view. But then you say, ‘here's a new fact,' and they'll go, ‘Oh, well, that changes things; you're right.'” Learning ability is more important than IQSucceeding in academia isn't always a sign of being able to do a job. Bock says that college can be an “artificial environment” that conditions students for one type of thinking. Want to hear something silly? Professors in American business schools usually have no experience in running a successful business. They're just repeating what they were told by someone else who was taught it by someone else who learned it from an endless string of bloodless people holding chalk in front of blackboards in drab little rooms. Why do we revere the graduates of these places? It would seem to me that the very definition of mediocrity would be, “a highly developed ability to repeat what you were told.” But you don't just repeat what you were told. You think for yourself. Mistakes don't frighten you. You learn from them. The smell of mediocrity does not follow you. You are not average. You have imagination and courage and humility and a marvelous sense of humor. You, my special friend, are a wonderful and valuable brand of crazy. Merry Christmas. Roy H. Williams